Close menu
Brain & Behavior
Grants & Prizes
Home
Research
Overview
Illness
Addiction
Anxiety Disorders
Attention-Deficit Hyperactivity Disorder (ADHD)
Autism Spectrum Disorder (ASD)
Bipolar Disorder
Borderline Personality Disorder (BPD)
Depression
Overview
Eating Disorders
Mental Illness (General)
Obsessive-Compulsive Disorder (OCD)
Post-Traumatic Stress Disorder (PTSD)
Schizophrenia
Suicide Prevention
Other Brain-Related Illnesses
Overview
Category
Basic Research
New Technologies
Early Intervention/ Diagnostic Tools
Next Generation Therapies
Blog
Get Involved
Overview
Give
Donate Today
Memorial/Tribute (make donation)
Create Event or Memorial Page
Find a Memorial/Tribute Page
Planned Giving
Stock/Securities Donations / IRA Charitable Rollovers
Overview
Other Giving Opportunities
Research Partners
Workplace Giving
Team Up for Research!
Sponsorship Opportunities
Overview
Watch
Healthy Minds TV
Meet the Scientists Webinars
Videos
Overview
Connect
Ask the Expert
Join Us
Home
Grants
Overview
Grant FAQs
Overview
NARSAD Young Investigator Grants
Overview
NARSAD Independent Investigator Grants
Overview
NARSAD Distinguished Investigator Grants
Prizes & Awards
Overview
Klerman & Freedman Prizes
Overview
Outstanding Achievement Prizes
Lieber Prize for Schizophrenia Research
Maltz Prize for Schizophrenia Research
Colvin Prize for Mood Disorders Research
Ruane Prize for Child and Adolescent Psychiatric Research
Goldman-Rakic Prize for Cognitive Neuroscience Research
Overview
The Pardes Humanitarian Prize
Overview
Productive Lives Awards
Blog
About Us
Overview
Who We Are
Overview
Our Impact
Overview
FAQs
Media Center
Overview
News
Press Releases
Opinion Pieces
In the News
Overview
Publications
Overview
Multimedia Library
Overview
Media Kit
Events & Webinars
Overview
Team Up for Research! Events
Healthy Minds TV
Contact
Email Signup
Open Menu

Menu

Are there new medications for schizophrenia in the works?

Go Back to the Questions

Q. Are there new medications for schizophrenia in the works?

Marc G. Caron, Ph.D.
Answer By: Marc G. Caron, Ph.D.
James B. Duke Professor of Cell Biology,
Duke University Medical Center

Marc G. Caron, Ph.D., of the Duke University Medical Center received the Lieber Prize for Outstanding Achievement in Schizophrenia Research from the Brain & Behavior Research Foundation in 2013. Learn more about the Outstanding Achievement Prizes at: http://bbrfoundation.org/outstanding-achievement-prizes.

Tags:
Schizophrenia
Ask an Expert

Related Articles

Evidence Links Abnormally Formed Proteins With Schizophrenia Pathology in Some Patients

READ

Posted: Thursday, June 13, 2019

Evidence Links Abnormally Formed Proteins With Schizophrenia Pathology in Some Patients

Read more
Research on Antioxidant Role in Schizophrenia and Psychosis Points to Possible Therapeutic Value of Compound Found in Broccoli

READ

Posted: Thursday, May 30, 2019

Research on Antioxidant Role in Schizophrenia and Psychosis Points to Possible Therapeutic Value of Compound Found in Broccoli

Read more
In a Comparison of Two Kinds of Cognitive Training, One Appeared to Help Schizophrenia Patients More

READ

Posted: Tuesday, April 9, 2019

In a Comparison of Two Kinds of Cognitive Training, One Appeared to Help Schizophrenia Patients More

Read more
Adding Guanfacine Boosted Benefits of Cognitive Remediation Therapy in Schizophrenia Spectrum Disorder

READ

Posted: Wednesday, January 30, 2019

Adding Guanfacine Boosted Benefits of Cognitive Remediation Therapy in Schizophrenia Spectrum Disorder

Read more